Ohman, Kerri A <br/><br/>
Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up.  [electronic resource] 

 -  HPB : the official journal of the International Hepato Pancreato Biliary Association  05 2017 
 - 449-457 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1477-2574 
<br/><br/><label>Standard No.: </label>10.1016/j.hpb.2017.01.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Pancreatic Ductal--mortality<br/>Chemoradiotherapy, Adjuvant--adverse effects<br/>Chi-Square Distribution<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease Progression<br/>Disease-Free Survival<br/>Dose Fractionation, Radiation<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Interferon-alpha--administration & dosage<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Missouri<br/>Multivariate Analysis<br/>Neoplasm Recurrence, Local<br/>Pancreatic Neoplasms--mortality<br/>Pancreaticoduodenectomy--adverse effects<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>Gemcitabine